Henna Kalsi, MD

Media Releases

Get to know Vascular Medicine Specialist and Phlebologist Dr. Henna Kalsi, who serves patients in Rochester and North Oaks, Minnesota.

A highly trained vascular medicine specialist and phlebologist, Dr. Kalsi is the Founder and Medical Director of JRK Vascular Medicine and Vein Clinic, a leading vascular medicine clinic in Rochester, Minnesota. She is also the Medical Director of Minnesota Vein Center.

Specializing in vascular medicine, phlebology, internal medicine and hypertension, she treats varicose veins, peripheral artery disease, aneurysm, restless legs syndrome, lymphedema, and cellulitis along with many other vascular conditions. She also offers noninvasive cosmetic treatments, including spider leg veins and face vein treatment. 

At JRK Vascular Medicine and Vein Clinic, the focus is squarely on the patient experience. The team strives to make every patient feel comfortable and confident about their care. Patients get the answers they need in a clear and easy-to-understand way, and Dr. Kalsi’s recommendations focus on the patient’s needs and goals before anything else. One of the reasons that so many patients love JRK Vascular Medicine and Vein Clinic is that they can count on seeing the doctor promptly and also on getting plenty of time to really discuss their situation.

The Minnesota Vein Center is a highly specialized medical practice dedicated to providing the most advanced chronic venous insufficiency, varicose vein, and spider vein treatment in Minnesota. The vein center near Minneapolis provides comprehensive vein care in a comfortable clinic environment, including expert consultation with vein specialists and state-of-the-art, minimally invasive treatments.

Graduating with her medical degree, Dr. Kalsi went on to perform her residency at the Medical College of Wisconsin Affiliated Hospitals. She then completed her fellowship in vascular medicine at Mayo Clinic and Cleveland Clinic.

As a fellow at Mayo Clinic, she invented body lumen occlusion apparatus and methods & novel technologies for minimally invasive varicose vein and blood vessel treatments. She then served as a Vascular Medicine Consultant on the faculty of the Cardiovascular Medicine Department at Mayo Clinic for 10 years. 

A Fellow of the Society for Vascular Medicine (FSVM), Dr. Kalsi is board-certified through the American Board of Vascular Medicine (ABVM) and the American Board of Internal Medicine  (ABIM). 

In addition, she holds certifications as a Registered Vascular Technologist (RVT), a Registered Physician in Vascular Interpretation (RPVI), and as a Certified Hypertension Specialist.

A firm believer in the old-fashioned approach to medicine, Dr. Kalsi strives to see patients promptly, to make sure that she answers all of their questions, and recommends the most effective treatments in every situation. She loves her work, and she also loves  Minnesota. With close to 20 years in the community, she has roots in the area and looks forward to serving patients in  Minnesota for years to come.

Vascular Medicine  is a subspecialty in which diseases of the vascular system, including the arteries, veins, and lymphatic circulation, are managed by medical therapy, minimally-invasive catheter procedures.  A vascular medicine specialist diagnoses, treats, and manages conditions in the arteries and veins, also called the blood vessels. These specialists treat a range of health problems, from spider and varicose veins to life-threatening aneurysms, and can help patients manage chronic conditions throughout their lives.

An authority in her field, Dr. Kalsi is extensively published in multiple peer-reviewed medical journals and regularly speaks at scientific conferences in the United States and around the world.

Among her various accolades include Patients’ Choice Award (2008, 2009, 2010, 2011, 2012, 2014, 2016, 2017, 2018), Compassionate Doctor Recognition (2010, 2011, 2012, 2014, 2017, 2018), Patients’ Choice 5th Anniversary Award (2012), and On-Time Doctor Award (2014, 2016, 2017, 2018).

Recommended Articles

• What Is Tachypnea?

  Introduction Tachypnea is a medical term, which means rapid and shallow breathing. This condition is often confused with hyperventilation, which is another type of abnormal breathing that is characterized by rapid but deep breathing. Both conditions are caused by carbon dioxide buildup in the...

• Lisinopril: What Are the Side Effects and Dosages of Lisinopril?

  The standard dose of this medication for adults with high blood pressure is 10 mg taken by mouth once a day.The doctor may increase the dose up to a maximum of 80 mg per day depending on the requirement. For heart failures, the starting dose for adults is 5 mg per day and the dosage can be increased...

• What is Blood Pressure, and How Is Blood Pressure Lowered?

  Modern day lifestyle does come with the risk of certain disease that is a result of everyday stress, poor eating habits, lack of exercise, and so on. While we are all aware of these diseases, we fail to take timely steps to prevent them from happening to us, and, by the time these strike, it is...

• How Does your Triglyceride Level Affect You?

  Triglycerides are produced as a product of breakdown of fats. It is also produced from carbohydrates to be stored as energy. Triglycerides are generally stored in fat cells and released when needed.The healthy range or normal level of triglycerides in the body is less than 150 milligrams per...

• What Are the Major Warning Signs of a Stroke?

  A stroke is one of the leading causes of death in the country. A stroke can be fatal if not treated immediately. Strokes can lead to disabilities, and affect the quality of life of a person considerably. Recognizing the symptoms and responding to the immediate needs is what is important in the...

• A New Form of Spaghetti Has Been Designed to Reduce the Risk of Heart Disease

  Scientists have developed ‘super spaghetti’, a variant of the normal form made from barley flour and this new form of noodles is supposed to reduce the risk of heart disease. Super spaghetti was developed by the scientists in Italy and Spain and the report is published in, Journal of...